Caldwell Sutter Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
4,379
+236
+6% +$19K 0.13% 164
2026
Q1
$359K Buy
4,143
+64
+2% +$6.13K 0.15% 151
2025
Q4
$392K Buy
4,079
+32
+0.8% +$3.11K 0.17% 138
2025
Q3
$385K Buy
4,047
+20
+0.5% +$1.84K 0.16% 140
2025
Q2
$351K Buy
4,027
+201
+5% +$17K 0.16% 140
2025
Q1
$344K Buy
3,826
+11
+0.3% +$984 0.16% 138
2024
Q4
$305K Sell
3,815
-68
-2% -$5.89K 0.14% 155
2024
Q3
$350K Buy
3,883
+46
+1% +$3.87K 0.16% 140
2024
Q2
$302K Sell
3,837
-11
-0.3% -$902 0.15% 150
2024
Q1
$335K Buy
3,848
+57
+2% +$4.87K 0.16% 143
2023
Q4
$312K Buy
3,791
+26
+0.7% +$1.98K 0.16% 135
2023
Q3
$295K Buy
3,765
+286
+8% +$23.9K 0.16% 137
2023
Q2
$307K Buy
3,479
+2,379
+216% +$205K 0.16% 136
2023
Q1
$88.7K Buy
+1,100
New +$89.7K 0.06% 195

Other funds holding MDT

Caldwell Sutter Capital's MDT Position: Q2 2026 in Review

Caldwell Sutter Capital increased its Medtronic (MDT) stake by 5.7% in Q2 2026, buying an estimated $19K and bringing the position to 4,379 shares worth $343K. The position accounts for 0.13% of the portfolio, ranked #164.

Caldwell Sutter Capital first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $392K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Caldwell Sutter Capital held 4,379 shares of Medtronic worth $343K as of Q2 2026.
  • Caldwell Sutter Capital bought 236 Medtronic shares in Q2 2026, an estimated $19K.
  • Medtronic made up 0.13% of Caldwell Sutter Capital's portfolio in Q2 2026, its #164 holding.
  • Caldwell Sutter Capital first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Caldwell Sutter Capital's Medtronic position peaked at $392K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.